Company registration number 15537784 (England and Wales)
CURO SKIN LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
CURO SKIN LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
CURO SKIN LTD
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
291
-
0
Tangible assets
4
13,224
-
0
13,515
-
0
Current assets
Stocks
3,839
-
Debtors
5
1,000
-
0
Cash at bank and in hand
5,659
1
10,498
1
Creditors: amounts falling due within one year
6
(102,444)
-
0
Net current (liabilities)/assets
(91,946)
1
Total assets less current liabilities
(78,431)
1
Provisions for liabilities
16,172
-
0
Net (liabilities)/assets
(62,259)
1
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
(62,260)
-
0
Total equity
(62,259)
1
CURO SKIN LTD
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 3 March 2026
Mr H Roden-Bilby
Director
Company registration number 15537784 (England and Wales)
CURO SKIN LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Curo Skin Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 124-128 City Road, London, England, EC1V 2NX.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover represents the invoiced value of goods supplied during the year, being shower filtration products sold to retail and trade customers.

Revenue is recognised when control of the goods has transferred to the customer, which is typically on dispatch of the products.

Turnover is stated net of value added tax, trade discounts, and returns.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
10% SL
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% SL
Computers
25% SL
CURO SKIN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

CURO SKIN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
CURO SKIN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
3
Intangible fixed assets
Other
£
Cost
At 1 January 2025
-
0
Additions
323
At 31 December 2025
323
Amortisation and impairment
At 1 January 2025
-
0
Amortisation charged for the year
32
At 31 December 2025
32
Carrying amount
At 31 December 2025
291
At 31 December 2024
-
0
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2025
-
0
Additions
16,367
At 31 December 2025
16,367
Depreciation and impairment
At 1 January 2025
-
0
Depreciation charged in the year
3,143
At 31 December 2025
3,143
Carrying amount
At 31 December 2025
13,224
At 31 December 2024
-
0
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
1,000
-
0
CURO SKIN LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
2,676
-
0
Taxation and social security
1,775
-
0
Other creditors
97,993
-
0
102,444
-
0
2025-12-31 2025-01-01 false false false 03 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr H Roden-Bilby 15537784 2025-01-01 2025-12-31 15537784 2025-12-31 15537784 2024-12-31 15537784 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 15537784 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 15537784 core:OtherPropertyPlantEquipment 2025-12-31 15537784 core:OtherPropertyPlantEquipment 2024-12-31 15537784 core:WithinOneYear 2025-12-31 15537784 core:WithinOneYear 2024-12-31 15537784 core:CurrentFinancialInstruments 2025-12-31 15537784 core:CurrentFinancialInstruments 2024-12-31 15537784 core:ShareCapital 2025-12-31 15537784 core:ShareCapital 2024-12-31 15537784 core:RetainedEarningsAccumulatedLosses 2025-12-31 15537784 core:RetainedEarningsAccumulatedLosses 2024-12-31 15537784 bus:Director1 2025-01-01 2025-12-31 15537784 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 15537784 core:PatentsTrademarksLicencesConcessionsSimilar 2025-01-01 2025-12-31 15537784 core:PlantMachinery 2025-01-01 2025-12-31 15537784 core:ComputerEquipment 2025-01-01 2025-12-31 15537784 2024-01-01 2024-12-31 15537784 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 15537784 core:OtherPropertyPlantEquipment 2024-12-31 15537784 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 15537784 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 15537784 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 15537784 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15537784 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 15537784 bus:FRS102 2025-01-01 2025-12-31 15537784 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 15537784 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP